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588 The Journal of Thoracic and Cardbjective: Delayed preconditioning genetically reprograms the response to ischemic
njury. Subclinical bacterial lipopolysaccharide acts through preconditioning, pow-
rfully protecting against experimental stroke. We investigated the potential for
ipopolysaccharide to protect against brain injury related to cardiopulmonary by-
ass.
ethods: Neonatal piglets were blindly and randomly preconditioned with lipo-
olysaccharide (n 6) or saline (n 6). Three days later, they experienced 2 hours
f deep hypothermic circulatory arrest before being weaned and supported anes-
hetized for 20 hours in an intensive care setting. Controls included cardiopulmo-
ary bypass without deep hypothermic circulatory arrest (n  3) and no cardiopul-
onary bypass (n  3). Brain injury was quantified by light and fluorescent
icroscopy (Fluoro-Jade; Histo-Chem, Inc, Jefferson, Ark).
esults: All animals were clinically indistinguishable before surgery. Perioperative
nd postoperative parameters between experimental groups were similar. No control
nimal scored falsely positive. Histologic scores were 0.33 0.21, 0.66 0.42, and
.5  0.24 in the cortex, basal ganglia, and hippocampus, respectively, in the
ipopolysaccharide-treated animals but significantly worse in all saline control
nimals (1.33  0.21, P  .01; 1.66  0.33, P  .09; and 6.0  1.5, P  .01). One
ipopolysaccharide-treated brain was histologically indistinguishable from controls.
onclusion: This is the first evidence that lipopolysaccharide can precondition
gainst cardiopulmonary bypass–related injury. Because lipopolysaccharide precon-
itioning is a systemic phenomenon offering proven protection against myocardial,
epatic, and pulmonary injury, this technique offers enormous potential for protect-
ng against systemic neonatal injury related to cardiopulmonary bypass.
reconditioning describes a concept whereby brief exposure to a harmful
stimulus in a dose below the threshold for tissue injury provides robust
protection against, or tolerance to, the injurious effects of a subsequent more
evere insult.1 Two forms of preconditioning exist—acute and delayed—which 
undamentally different in nature. Acute preconditioning occurs within minutes and
rovides protection for a number of hours. It has been extensively studied, espe-
ially in the context of myocardial injury. Delayed preconditioning offers a far
reater window of protection. The protective effects begin after 24 to 48 hours but
ontinue for as long as 7 to 14 days.2 Delayed preconditioning of the brain is
idely established experimental phenomenon in rodent models of regional and
lobal ischemia, but this concept has not previously been applied to ischemic brain
njury resulting during cardiopulmonary bypass (CPB).
A widely recognized trigger for delayed preconditioning is bacterial lipopoly-
accharide (LPS) and its derivatives. Systemically administered in extremely low
iovascular Surgery ● June 2007
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Poses, it provides protection against a variety of subsequent
nsults, including myocardial, renal, liver, and cerebral ische-
ia, where infarct volume can be reduced by as much as
0%.2 Evidence has recently emerged suggesting that -
ayed preconditioning involves a complete reprogramming
t the genetic level, to provide systemic protection against
oth ischemic injury3 and activation of components of t
ellular immune response.4 This concept, therefore, is e-
remely appealing in the context of ischemic CPB-related
njury, where systemic inflammation, hypoxia–ischemia,
nd reperfusion injury act synergistically to cause end-organ
amage.
Because LPS preconditioning consistently induces ro-
ust protection against ischemic brain injury in experimen-
al rodents, we entertained the hypothesis that low-dose LPS
ay confer cerebral protection against ischemic injury sus-
ained during periods of neonatal deep hypothermic circu-
atory arrest (DHCA). Using a piglet model of DHCA,
nvolving a 20-hour reperfusion period in a fully monitored
ntensive care environment, we aimed to test this hypothesis
y histologically quantifying regional brain injury after
nimals were blindly and randomly inoculated before sur-
ery with either a preconditioning dose of LPS or saline
lacebo.
aterials and Methods
xperimental Design
welve neonatal piglets were inoculated intravenously, randomly,
nd blindly, with either normal saline (saline control group) or 20
g/kg Escherichia coli bacterial LPS (serotype 0111:B4, Sigma-
ldrich Corp, St Louis, Mo) (LPS group). Inoculation was per-
ormed under brief general anesthesia (1% isofluorane). After
ecovery, they were observed closely for the first 24 hours for
dverse signs, including sickness, lethargy, or sepsis. Three days
72 hours) later, animals were placed on full open-chested CPB
nd subjected to 2 hours of DHCA at 18°C. After rewarming and
eparation from CPB, the animals were supported anesthetized and
entilated with full invasive monitoring for a further 20 hours
warm reperfusion period) before being perfusion-fixed. Brain
issue was extracted for histologic and fluoroscopic (Fluoro-Jade;
isto-Chem Inc, Jefferson, Ark) scoring of neurologic injury in the
rontal lobe cortex, basal ganglia, hippocampus, and cerebellum.
istologic controls included nonischemic controls (n  3) sub-
ected to 2 hours of deep hypothermic full-flow CPB with 20 hours
Abbreviations and Acronyms
CPB  cardiopulmonary bypass
DHCA deep hypothermic circulatory arrest
LPS  lipopolysaccharide
TLR  Toll-like receptor
TNF  tumor necrosis factorf postbypass reperfusion and experimental shams (n  3) anes- a
The Journal of Thoracichetized and instrumented but not placed on CPB, humanely killed
0 hours later.
urgical Procedures
ll animal experiments were conducted with the approval of the
nstitution’s Animal Care and Use Committee. The animals re-
eived humane care in compliance with the “Guide for the Care
nd Use of Laboratory Animals” published by the National Insti-
utes of Health (NIH publication No. 85-23, revised 1995).
The surgical protocol, including CPB circuit and prime, was
imilar to that described previously by our laboratory.5 In brief,
fter anesthetic induction (1% isofluorane) and placement of pe-
ipheral lines and temperature probes, surgical tracheotomy was
erformed to allow controlled ventilation, maintaining arterial
xygen and carbon dioxide tensions within normal limits.
The heart was exposed via a median sternotomy. After systemic
eparinization (500 IU/kg), the aortic root and right atrial append-
ge were cannulated and CPB was established at 100 to 150 mL ·
g1 · min1 to maintain mean arterial pressures of 50 mm Hg.
he animal was then perfusion-cooled with a pH-stat strategy to
8°C over 30 minutes. CPB was then ceased and the circulatory
olume drained into the reservoir to induce uninterrupted circula-
ory arrest for 120 minutes. During this period, myocardial pro-
ection was afforded by slowly perfusing through an isolate
oronary circulation. An aortic crossclamp was applied to the
scending aorta immediately distal to the aortic cannula, and soft
lips were applied to the inferior and superior venae cavae, thereby
solating the coronary circulation through which cold blood was
dministered at a rate of 5 to 10 mL/min. Full-flow CPB was later
e-established and the animal rewarmed, with the administration of
arbonate (8.4%) to correct acidosis. The lungs were ventilated
nd the animals separated from CPB in conjunction with a con-
inuous infusion of intravenous norepinephrine (2 mL/h) and vol-
me replacement as necessary.
ostoperative Care
rotamine was administered (5 mg/1000 IU heparin), drains and
ladder catheters were positioned, and all wounds were closed.
nimals were then supported in a laboratory intensive care, anes-
hetized (intravenous propofol 3-5 mL/h), and ventilated, with
ully alarmed invasive monitoring and continuous veterinary sup-
ort. The arterial pressure was maintained with a mean greater than
0 mm Hg. After 20 hours of reperfusion, the animals were
xsanguinated, irrigated (3 L of saline), and perfusion-fixed (2 L of
ce-cold 4% paraformaldehyde). The brains were retrieved intact
efore being sectioned coronally, embedded in paraffin blocks, and
-m slices mounted on slides for staining with hematoxylin and
osin or Fluoro-Jade.
taining with Fluoro-Jade
luoro-Jade is an anionic fluorochrome that selectively stains
rreversibly injured neurons with greater sensitivity and specificity
han hematoxylin and eosin.6 After deparaffinization, slides wer
mmersed for 20 minutes in 0.06% potassium permanganate before
eing washed several times in deionized water. Fluoro-Jade crys-
als were dissolved to a 0.0004% solution in 0.01% acetic acid
nd the slides were immersed for 20 minutes before thorough
ir-drying in a warm incubator. After xylene washes, slides
and Cardiovascular Surgery ● Volume 133, Number 6 1589
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CSPere covered and viewed with an epifluorescent microscope
ith blue (450-490 nm) excitation light. A barrier filter allow-
ng passage of all wavelengths longer than 515 nm results in a
reen emission color from cells stained positively with
luoro-Jade.
istologic Scoring
lides were examined randomly by investigators blinded to the
xperimental protocol. Morphologic criteria used to identify ische-
ic neurons were a prominent eosinophilic nucleus, with lack of a
ell-defined nucleolus and Nissl substance, together with nuclear
ragmentation and formation of dark apoptotic bodies.7 These are
stablished signs of irreversible neuronal injury and avoid false-
ositive identification of hyperchromatic neuronal artifact.7 Qual-
tative grading scores were applied according to the cerebral cor-
ex, basal ganglia, hippocampus, and cerebellum (where 0 
ormal and 4  confluent, severe injury). The hippocampus is
now to exhibit regional vulnerability, and therefore subregions
CA1, CA2, CA3, CA4, and superficial, middle, and deep dentate
yrus) were selectively scored, inasmuch as repeated studies with
ur model have demonstrated reproducible hierarchical injury
ithin these areas.
tatistical Analysis
ll data are expressed as mean  standard error of the mean. The
npaired Student t tests were used to compare perioperative pa-
ameters and quantitative histologic scores between animals in the
aline and LPS preconditioned groups or otherwise analysis of
ABLE 1. Experimental CPB parameters for the two exper-
mental groups (LPS-preconditioned and saline control [un-
reconditioned])
Saline control LPS P value
eight (kg) 2.8 .18 3.3  .50 .43
ematocrit (%) 28.5 1.9 27.8  1.9 .81
H 7.36 .04 7.39  .64 .64
ase deficit (mmol/L) 5.3  2.1 –2.0 2.4 .33
aO2 (mm Hg) 245 39 308  47 .35
aCO2 (mm Hg) 33  5.1 36  3.3 .68
AP (mm Hg) 45.0 2.3 50.8  4.4 .30
eart rate (beats/min) 117 5.4 131..1 .08
ore temp (°C) 37.3 .32 36.7  .58 .54
ooling duration (min) 27.5 2.5 25.8  2.0 .61
ewarm duration (min) 52.5 5.1 50.0  4.1 .71
otal CPB duration (min) 201 4.6 195  4.6 .38
ase deficit at 25°C during
rewarm (mmol/L)
–13.8 2.2 –11 1.3 .33
CO3 (mL) 21  2.0 17  .3 .31
H at wean 7.41 .03 7.42  .05 .95
ase deficit at wean
(mmol/L)
3.2  1.9 –3.7 2.0 .86
aO2 at wean (mm Hg) 316 48 245  56 .38
aCO2 at wean (mm Hg) 29  3.7 28  4.6 .85
ematocrit at wean (%) 34 1.7 32  2.5 .65
PB, Cardiopulmonary bypass; LPS, lipopolysaccharide.ariance to compare values between groups with SAS statistical s
590 The Journal of Thoracic and Cardiovascular Surgery ● Junoftware (SAS, Inc, Cary, NC). Statistical significance was tested
o the 95% confidence limit.
esults
erioperative Parameters
ll animals survived the experiment. Preoperatively, an-
mals were indistinguishable; none exhibited signs of ill
ealth or required veterinary intervention. The preoper-
tive and CPB parameters of the two experimental groups
LPS and saline control) are given in Table 1. Post
tive parameters during the recovery period are provided
n Table 2.
istologic Scores of Injury
istologic scores for each animal in the representative
egions and subregions are given in Table 3 and Figu
mportantly, no false-positive scoring for injury occurred
n any specimen from a sham or nonischemic control
nimal. All animals in the saline control group exhibited
istologic evidence of ischemic injury in the cortex, basal
anglia, and especially the hippocampus. The regional
ulnerability within the hippocampus is interesting, be-
ause conventionally the large CA1 neurons are regarded
s the most sensitive to ischemic injury in the mammalian
rain. Our laboratory consistently observes the pattern of
ippocampal injury seen herein—the superficial region of
he dentate gyrus is the most sensitive to injury, and with
rogressively more severe injury, ischemic neurons are
hen noted proportionately deeper within the dentate and
hen into the (adjacent) CA4. Similar dentate gyrus sus-
eptibility has been noted by others8 24 to 48 hours aft
schemia. No injury was detected in the cerebellum of
ny animal, even in the large Purkinje neurons.
Every animal preconditioned with LPS displayed signif-
cantly reduced histologic injury in the cortex and hip-
ocampal subregions, regardless of whether scores were
onsidered cumulatively or not. In fact, animal No. 5 in the
PS-preconditioned group exhibited no evidence of isch-
mic injury, such that specimens from all its respective
rain regions were indistinguishable from those of nonisch-
mic control and sham animals.
Fluoroscopic assessment with Fluoro-Jade reiterated
he changes observed by light microscopy (Table 4 
igure 2). Fluoro-Jade is highly sensitive and specific
rreversible neuronal injury and makes identification of
ositive neurons straightforward (Figure 3). Every br
egion examined in this study except the cerebellum
xhibited significantly lesser injury by Fluoro-Jade as-
essment after LPS preconditioning. No false-positive
cores were observed in either the nonischemic control or
ham animals.
In summary, both by light microscopic and by fluoro-
copic criteria, LPS-preconditioned animals displayed sig-
e 2007
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Pificantly reduced ischemic neuronal injury over their coun-
erparts inoculated with saline placebo.
iscussion
his study describes the first successful application of de-
ayed preconditioning with LPS in a model of CPB-related
schemic brain injury. In contrast to neuroprotective strate-
ies targeting clinical stroke, which lacks a well-defined
re-aura, preconditioning against CPB-related ischemic
rain injury is a far more applicable concept. In fact, CPB
nvolving periods of circulatory arrest is the only circum-
tance in which a (controlled) severe global ischemic hit is
outinely administered to the brain in a premeditated
ashion.
Cerebral preconditioning is not a new idea. Several acute
reconditioning techniques are widely established experi-
entally, in particular brief hypoxia–ischemia (or hypoxia
ABLE 2. Postoperative variables
roup After wean 4
ean arterial pressure (invasive) (mm Hg)
Saline 48.8 4.8 48
LPS 57.8 6.4 53
P .29
eart rate (beats/min)
Saline 137 6 1
LPS 127 7 1
P .32
O2 (mm Hg)
Saline 298 57 2
LPS 237 32 2
P .41
CO2 (mm Hg)
Saline 34  2.6 43
LPS 36  4.4 43
P .64
H
Saline 7.31 .03 7.
LPS 7.33 .02 7.
P .67
ase excess (mmol/L)
Saline 7.5  .8 5
LPS 3.9  1.4 3
P .06
ematocrit (%)
Saline 32.1 1.3 28
LPS 31.3 1.4 30
P .79
emperature (°C)
Saline 36.0 .3 36
LPS 36.4 .5 37
P .50
values compare animals between experimental groups inoculated withimetics9) . It is surprising, therefore, that these techniquesi
The Journal of Thoracicere tested against CPB-related brain injury only recently9,10
he initial application t o C P B b y Y e h a n d associates,10
nvolved the use of acute ischemic preconditioning. By
ontrast, delayed preconditioning is a considerably more
ppealing concept, not least because it offers a significantly
reater window of protection and potency.2 In clinical
erms, for example, a 7-day window of tolerance would
pan the entire operative and intensive care periods, during
hich numerous compounding factors are believed to in-
uence progression of the initial injury.
Although several agents, including ischemia–hypoxia
and their mimetics9), can induce delayed protection, L
nd its derivatives are among the most closely studied. LPS
reconditioning was originally noted to confer protection
gainst subsequent lethal doses of LPS (homologous toler-
nce).11 However, it also exhibits cross-tolerance, where
onlethal stress confers tolerance to a subsequent stress that
s 8 hours 12 hours 16 hours 20 hours
4.8 53.3 4.3 57.4 3.1 50  3.5 51  3.2
5.4 64  4.4 60  5.1 56  3.7 56  4.8
.12 .68 .27 .43
8 150  9 154  6 166  5 166  4
7 157  5 165  6 163  9 152  7
.54 .30 .79 .16
43 215 24 173 33 192 32 241 17
39 149 9.8 209 17 249 27 268 53
.03 .37 .28 .64
3.4 37.5 3.1 43.0 3.7 35.6 2.3 36.0 2.3
3.2 45  1.3 47.5 4.5 41.0 2.2 33.0 5.2
.04 .49 .08 .51
.03 7.43 .03 7.43 .05 7.47 .02 7.47 .02
.03 7.36 .03 7.37 .04 7.45 .04 7.53 .05
.16 .40 .66 .32
.9 0.9  .8 2.9  .9 2.9  1.9 3.9  1.2
2.5 0.2  2.3 2.7  2.1 4.9  1.8 5.6  2.6
.66 .94 .38 .55
.9 31.2 2.1 32.2 1.9 36  1.4 34  1.3
2.4 31.6 1.7 34.2 1.7 36  3.4 32.5 3.1
.89 .31 .92 .70
.5 37.0 .6 37.2 .4 37.3 .6 37.2 .23
.7 37.9 .4 36.9 .7 37.8 .4 37.1 .5
.31 .68 .56 .85
lipopolysaccharide (LPS) or saline control.hour
.8
.5
.48
43 
42 
.99
17
25
.89
.3
.0
.94
32
31
.81
.1 
.9 
.66
.8
.8
.56
.7
.1
.60s different in nature from the first. Thus, systemic LPS has
and Cardiovascular Surgery ● Volume 133, Number 6 1591
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CSPow been shown to also induce ischemic tolerance in sev-
ral systems including the liver, myocardium, kidney, and
rain.11-13 In fact, the characteristics of LPS preconditi-
ng appear to share several hallmark features with delayed
schemic preconditioning in the brain,11 suggesting that
ommon pathways may link the numerous primary precon-
itioning stimuli.
Rodent models generating large infarct zones consis-
ently demonstrate reduction of injury by as much as 60%
fter systemic LPS inoculation.2 Histologic models of injur
fter DHCA instead require extended ischemic periods to
enerate scattered evidence of ischemic injury.9,14,15 These
xtended durations of DHCA represent a departure from
linical practice and are therefore a significant limitation in
he experimental study of DHCA. Nevertheless, whereas all
onpreconditioned animals in this present study displayed
rain injury in all regions other than cerebellum, brain
egions from some of the preconditioned animals were
ndistinguishable from control groups, with no ischemic
he respective experimental groups by light microspcopy,
Hippocampus HCamp
total
Cumul
totalCA4 DG sup DG med DG deep
2 3 2 0 8 10
3 3 1 1 11 15
1 2 1 0 5 7
0 0 0 0 0 2
1 3 1 0 5 8
2 3 2 0 7 12
1.5  0.43 2.33 0.5 1.2 0.31 0.17 0.17 6.0 1.5 9  1.8
0 1 0 0 1 1
0 0 0 0 0 1
1 0 0 0 1 1
0 1 0 0 1 4
0 0 0 0 0 0
0 0 0 0 0 2
.17 0.17 .33  .21 0 0 0.5  0.22 1.5 0.6
.016 .004 .004 .34 .005 .003
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
ores are indicated in the far right columns. LPS, Lipopolysaccharide; DG,igure 1. Graphic illustration of the histologic injury in frontal lobe
ortex, basal ganglia, and hippocampus occurring in the LPS-precon-
itioned and saline control groups, as determined by routine light
icroscopy. **P < .01; n/s, not significant. Cor, Cortex; BG, basalABLE 3. Individual histologic scores assigned to animals in t
ncluding controls
nimal Cortex
Basal
ganglia Cerebellum CA1 CA2 CA3
aline
1 1 1 0 0 0 1
2 2 2 0 0 0 3
3 1 1 0 0 0 1
4 1 1 0 0 0 0
5 1 2 0 0 0 0
6 2 3 0 0 0 0
Mean 1.33  0.21 1.67 0.33 0 0 0 0.83 0.48
PS
1 0 0 0 0 0 0
2 1 0 0 0 0 0
3 0 0 0 0 0 0
4 1 2 0 0 0 0
5 0 0 0 0 0 0
6 0 2 0 0 0 0
Mean 0.33  0.21 0.67 0.42 0 0 0 0 0
P, LPS vs
saline
.007 .09 — — — .11
onischemic
control
1 0 0 0 0 0 0
2 0 0 0 0 0 0
3 0 0 0 0 0 0
ham
1 0 0 0 0 0 0
2 0 0 0 0 0 0
3 0 0 0 0 0 0
umulative hippocampal (HCampal total) and overall cumulative (Cumul total) scnjury apparent, suggesting a robust protective effect. The
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Premise on which exaggerated animal DHCA models are
sed is that observed protection should translate to some
egree of protection against clinical DHCA injury, however
light. In addition, the protection demonstrated in this
resent study is important for several reasons: (1) LPS
reconditioning has never been tested in conjunction with
PB; (2) although descriptions of LPS preconditioning exist
n swine,16 none have examined cerebral protection; and 
onflicting reports exist as to whether or not the neonatal
ammalian brain is amenable to preconditioning.17-19
onclusions
onsiderable energy has recently been spent elucidating the
echanisms underlying preconditioning. Acute and delayed
orms are fundamentally different. Acute preconditioning
robably involves posttranslational processing and may
ave several features in common with myocardial precon-
itioning, including the role of nitric oxide,20 adenosine A1
eceptors,21 and adenosine triphosphate– dependent pota-
respective experimental groups by Fluoro-Jade including
Hippocampus HCamp
total
Cumul
totalCA4 DG sup DG med DG deep
2 3 2 0 8 13
2 3 2 0 7 10
1 3 2 0 6 11
0 1 0 0 1 3
2 3 2 0 8 11
1 3 2 0 6 11
1.33  0.33 2.67  0.33 1.67  0.33 0 6.0 1.1 9.8 1.4
0 2 1 0 3 5
0 0 0 0 0 0
0 1 0 0 1 3
1 1 1 0 3 5
0 0 0 0 0 0
0 0 0 0 0 2
0.17  0.17 0.67  0.33 0.33  0.21 0 1.2 0.6 2.5 0.9
.011 .002 .007 — .003 .002
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
ores are indicated in the far right columns. LPS, Lipopolysaccharide; DG,igure 2. Graphic illustration of the histologic injury in frontal
obe cortex, basal ganglia, and hippocampus occurring in the
PS-preconditioned and saline control groups, as determined by
luoroJade staining. **P <. 01. Cor, Cortex; BG, basal ganglia;ABLE 4. Individual histologic scores assigned to animals in the
ontrols
nimal Cortex
Basal
ganglia Cerebellum CA1 CA2 CA3
aline
1 2 3 0 0 0 1
2 2 1 0 0 0 0
3 2 3 0 0 0 0
4 0 2 0 0 0 0
5 1 2 0 0 0 1
6 2 3 0 0 0 0
Mean 1.5  0.34 2.33 0.33 0 0 0 0.33  0.21
PS
1 1 1 0 0 0 0
2 0 0 0 0 0 0
3 1 1 0 0 0 0
4 1 1 0 0 0 0
5 0 0 0 0 0 0
6 0 2 0 0 0 0
Mean 0.5  0.22 0.8 0.31 0 0 0 0
P, LPS vs
saline
.034 .002 — — — .15
onischemic
control
1 0 0 0 0 0 0
2 0 0 0 0 0 0
3 0 0 0 0 0 0
ham
1 0 0 0 0 0 0
2 0 0 0 0 0 0
3 0 0 0 0 0 0
umulative hippocampal (HCampal total) and overall cumulative (Cumul total) scium channels.21 By contrast, delayed preconditioning is an
and Cardiovascular Surgery ● Volume 133, Number 6 1593
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CSPctive process. It involves an endogenous program of neu-
oprotection22,23 featuring a complex cascade of intracel-
ar signaling events leading to new synthesis of proteins23,24
hat ultimately reprograms the cellular response to subse-
uent injury.
LPS is a ligand for Toll-like receptor (TLR)-4.25 TLRs
re evolutionary historic transmembrane proteins that rec-
gnize generic constituents of foreign bacteria (double-
tranded RNA, unmethylated DNA sequences, and LPSs) to
rigger downstream inflammatory pathways. In addition,
owever, it is recognized that injured and necrotic cells also
elease endogenous ligands, including RNA, chromosomal
NA, heat shock proteins, and components of extracellular
atrix.26 TLRs may therefore represent the common pa-
ay linking diverse initiators of delayed preconditioning.
One theory proposed26 is that a very low level of s-
lation of TLRs (either through exogenous LPS or endog-
nous components generated through a preconditioning
timulus such as subinjurious ischemia), together with
roinflammatory cytokines (tumor necrosis factor- [TNF-
], interleukin-1), results in downstream generation of both
roinflammatory and anti-inflammatory cytokines. In addi-
ion, suppressors of inflammation are produced, which in-
lude decoy receptors and decoy ligands. During the second
timulation, these decoys and anti-inflammatory cytokines
redominate, resulting in an overall reduction in tissue
njury. Alternatively, if the initial preconditioning stimulus
xceeds beyond a threshold dose, the initial response is
verwhelmed by pro-inflammatory processes, and the pre-
Figure 3. Representative images of hippocampal (den
control (unpreconditioned ) brains stained with Fluor
positive cells are clearly discernible, littering the graonditioning response will not occur. Thus, preconditioning a
594 The Journal of Thoracic and Cardiovascular Surgery ● Juns similar to a “trip switch.” If the preconditioning dose falls
bove the threshold, the trip is flipped, and tissue injury will
ccur instead.
The above hypothesis would explain several conun-
rums, including the paradox as to why an obligatory step in
he delayed preconditioning process is the generation of
otentially harmful inflammatory mediators. TNF- in par-
icular, and its downstream signaling mediator ceramide, are
ritical effectors of LPS-induced neuroprotection.27,28 LPS
reatment accompanied by concomitant neutralizing anti–
NF- reverses the protective effect of LPS precondition-
ng.11 Further downstream, the effector pathways are l
lear, but one suggestion that is gathering support involves
central role of interferon-, secondary to the TNF-signal-
ng axis (reviewed in reference 1). A neuroprotective role of
nterferon- is supported by the recent finding that its sys-
emic administration improves stroke outcome.29
The precise cascade of intracellular signaling events is
learly complex. However, the end result appears to be an
ntire genetic reprogramming of the genomic response to
njury, which shifts the balance of outcome from cell death
o cell survival.3 Microarray genome survey analysis su-
ests this genetic switch mimics the pattern seen in hiber-
ation.3 Thus, as in hibernation, preconditioning elicits -
ogenous genetic adaptations that confer tolerance to the
njurious effects of oxygen deprivation.
Of particular interest is the effect of delayed precondi-
ioning on aspects of the inflammatory response,4 because
nflammatory processes are increasingly being recognized
gyrus) sections from LPS-preconditioned and saline
de as viewed through a fluorescent microcope. The
cell layer of the dentate. LPS, Lipopolysaccharide.tate
o-Ja
nulars crucial propagators of ischemic brain injury. Rodent
e 2007
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Ptudies have recently demonstrated that although the total
ellular infiltrate into the infarct zone is not different after
reconditioning, the number of activated neutrophils is sig-
ificantly reduced, as determined by reduced CD11b ex-
ression.4 The notion that delayed preconditioning mig
lter the profile of the systemic inflammatory response is of
uge significance to CPB-related injury and clearly is an
xciting area for future study.
The application to functional models represents another
venue for future investigation. We chose to use a model
uantifying histologic neuronal injury because this remains
frequently used and reliable index of ischemic brain
njury. Fluoro-Jade is especially sensitive for injured neu-
ons, greatly facilitating their detection. Others have instead
sed markers of apoptosis or even functional outcome.
lthough difficult and crude in swine, functional models
epresent the proof of concept that we are intending to
ursue in future studies. Microarray genome survey has
dditionally proved a valuable tool for both quantifying
esponse to injury and providing insight into the putative
echanisms of preconditioning,3 and we are actively pu-
uing this technique in swine models at present.
One obstacle to the clinical application of LPS precon-
itioning is the risk posed by administering a potentially
ethal substance to clinically vulnerable patients, irrespec-
ive of the tiny doses necessary. Interestingly, specific li-
ands for individual TLR subtypes have been shown to
isplay cross-tolerance.30 For example, lipoteichoic aci
referentially binds TLR-2 and will induce tolerance to LPS
TLR-4) and visa versa. Future efforts should therefore
xplore the possibility that additional less noxious TLR
igands can be identified that confer similar protection to
PS through TLR cross-tolerance.
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